Market Overview

Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Revenue

Share:
Related FRX
Icahn's (Potential) Move Into Biotech
Carl Icahn's Track Record In Big Pharma
Related ENDP
28 Stocks Moving In Monday's Pre-Market Session
44 Biggest Movers From Friday
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q3 2017 Update (Seeking Alpha)

Below are the top mid-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of revenue.

The trailing-twelve-month revenue at Forest Laboratories (NYSE: FRX) is $3.82 billion. Forest Laboratories' ROE for the same period is 9.98%.

The trailing-twelve-month revenue at Endo Health Solutions (NASDAQ: ENDP) is $3.03 billion. Endo Health's PEG ratio is 0.90.

The trailing-twelve-month revenue at Warner Chilcott plc (NASDAQ: WCRX) is $2.58 billion. Warner Chilcott had $304.00 million in total cash for the latest quarter.

The trailing-twelve-month revenue at Dr. Reddy's Laboratories (NYSE: RDY) is $2.05 billion. Dr. Reddy's operating margin for the same period is 20.84%.

Posted-In: Drug Manufacturers-Other Industry Highest Revenue Mid-CapTrading Ideas

 

Related Articles (ENDP + FRX)

View Comments and Join the Discussion!

Partner Center